EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early and Mid-Term Ultrasound Response to Guselkumab in Psoriatic Arthritis: A Real-World Cohort from a Single Tertiary Rheumatology Center

Filippo Messina, Massimo Caimi, Linda Lucchetti, Marco Bonifacio, Emanuele Fiorino, Alessandro Conforti

Journal of Clinical Medicine · 03.02.2026 · 15 (3) · 1196

DOI: 10.3390/jcm15031196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.02.2026. Verfasst von Filippo Messina und 5 weiteren Autor:innen. Beteiligte Einrichtung: ASL Roma 4, 00053 Civitavecchia, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To quantify early and mid-term changes in ultrasound-detected synovitis and enthesitis after initiating guselkumab in psoriatic arthritis (PsA) and to contextualize imaging responses alongside clinical outcomes.

Methods

We conducted a retrospective single-center cohort study of consecutive CASPAR-classified adults (n = 20) initiating guselkumab 100 mg (week 0/week 4, then q8w; q4w intensification per routine practice). Power Doppler ultrasound (PDUS) followed EULAR–OMERACT standards at baseline (T0), Month 3 (T3), and Month 6 (T6). The primary endpoint was within-patient change in 24-joint GLOESS. Secondary endpoints included OMERACT entheseal scores (activity-only; activity + structure), DAPSA states, PASI, and 6-month persistence. Within-patient changes were assessed using Wilcoxon signed-rank tests (two-sided).

Results

All 20 patients completed T6. GLOESS decreased from T0 to T3 (mean Δ −4.05 ± 2.78; p = 0.0312) and to T6 (mean Δ −5.70 ± 4.05; p = 0.0001). Component summaries showed a numerically larger early decrease in synovial PD signal than in grayscale synovial hypertrophy (descriptive). Enthesitis scores improved: OMERACT activity-only median Δ −2.0 at T3 (p = 0.0313) and −3.5 at T6 (p = 0.016); activity + structure median Δ −1.5 at T3 (p = 0.0412) and −3.0 at T6 (p = 0.031). The estimated structural component (OMERACT-1 minus OMERACT-2) was similar across visits (descriptive), indicating improvements driven predominantly by inflammatory signal suppression rather than detectable changes in structural lesions over 6 months. Among patients with baseline PD-positive enthesitis (n = 7), PD negativity (OMERACT-2 = 0) occurred in 2/7 (28.6%) by T6. Clinical domains (DAPSA, PASI) improved in parallel, and 6-month persistence was high.

Conclusions

In routine care, guselkumab was associated with a significant improvement in PD-inclusive ultrasound synovitis scores by 3 months, which deepened by 6 months, alongside an improvement in entheseal activity measures. Over 6 months, entheseal structural burden appeared stable; these findings should be considered hypothesis-generating and warrant confirmation in prospective controlled studies.

Schlagwörter

Stichwörter der Autor:innen

GLOESSOMERACT scoringenthesitisglobal synovitis scoreguselkumabpower doppler ultrasoundpsoriatic arthritis

Autor:innen und Institutionen

  • ASL Roma 4, 00053 Civitavecchia, Italy.
  • Fisioterpia Medica, 00144 Rome, Italy.

Zitieren

APA

Messina, F., Caimi, M., Lucchetti, L., Bonifacio, M., Fiorino, E., & Conforti, A. (2026). Early and Mid-Term Ultrasound Response to Guselkumab in Psoriatic Arthritis: A Real-World Cohort from a Single Tertiary Rheumatology Center. Journal of Clinical Medicine, 15(3), 1196. https://doi.org/10.3390/jcm15031196

Vancouver

Messina F, Caimi M, Lucchetti L, Bonifacio M, Fiorino E, Conforti A. Early and Mid-Term Ultrasound Response to Guselkumab in Psoriatic Arthritis: A Real-World Cohort from a Single Tertiary Rheumatology Center. Journal of Clinical Medicine. 2026;15(3):1196. doi:10.3390/jcm15031196

BibTeX
@article{Messina2026,
  author = {Messina, Filippo and Caimi, Massimo and Lucchetti, Linda and Bonifacio, Marco and Fiorino, Emanuele and Conforti, Alessandro},
  title = {Early and Mid-Term Ultrasound Response to Guselkumab in Psoriatic Arthritis: A Real-World Cohort from a Single Tertiary Rheumatology Center},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {1196},
  doi = {10.3390/jcm15031196}
}
Kostenlos starten →